Firefly Neuroscience Secures $8M Private Placement at $1.50/Unit; Investors Agree to 30-Day Lock-Up
AIFF has more than doubled off its 52-week low of $0.618 on light trading volume (0.2× avg).
Summary
Firefly Neuroscience completed an $8 million private placement on April 16, 2026, issuing 5,333,333 units at $1.50 per unit to an accredited investor. This capital raise is critical for the company, which previously issued a going concern warning in its last 10-K and relies on dilutive financing. The $8 million represents a substantial portion of its approximately $33 million market capitalization. The financing provides much-needed liquidity to support operations, addressing the company's significant financial risks, though the $1.50 per unit price is below the current stock price, indicating dilution for existing shareholders. A key detail is the 30-day lock-up agreement for investors, preventing immediate selling pressure until May 16, 2026, which could help stabilize the stock post-financing. The company also extended the deadline to file the related resale registration statement to May 21, 2026.
At the time of this announcement, AIFF was trading at $2.22 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $33M. The 52-week trading range was $0.62 to $4.51. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Wiseek News.